Skip to main content

Table 2 Tumor-associated antigens for generation of rFc fusion proteins

From: Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality

Gene

Accession #

Signal Sequence Amino Acids

Encoded Amino Acid Fragment

20 Original Antigens

   

 ANGPTL4

NM_139314

1–30

31–406

 CD147

NM_198589

1–21

22–162

 CD320

NM_016579

1–46

47–230

 CDH3

NM_001793

1–24

25–654

 CST2

NM_001322

1–20

21–141

 DKK1

NM_012242

1–28

29–266

 EPHA2

NM_004431

1–26

27–535

 GFRA1

AF038421

1–24

25–465

 GRN

NM_002087

1–17

18–593

 ERBB2

NM_004448

1–22

23–652

 IGFBP2

NM_000597

1–39

40–328

 LAMC2

NM_005562

1–21

22–1111

 LGALS1

NM_002305

1–17

18–135

 LRP10

NM_014045

1–16

17–440

 LRRC15

NM_001135057

1–27

28–544

 MUC1

NM_002456

1–22

23–167

 SPINT2

NM_021102

1–27

28–198

 SPON2

NM_012445

1–26

27–331

 SSR2

NM_003145

1–17

18–146

 SUSD2

NM_019601

1–27

28–785

12 Additional Antigens

   

 A1AT

NM_000295.4

1–24

25–418

 AMACR

NM_014324.5

None

1–382

 BIRC5

NM_001168.2

None

1–142

 CALD1

NM_033139.3

None

1–558

 CAPC

NM_001013653.2

1–26

27–264

 CCNB1

NM_031966.3

None

1–433

 CCND1

NM_053056.2

None

1–295

 GRP78

NM_005347.4

None

1–654

 LGALS3

NM_002306.3

None

1–250

 MYC

NM_002467.4

None

1–439

 NY-ESO-1

NM_001327.2

None

1–180

 XAGE1

NM_001097594.2

None

1–81